Biodesix, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BDSX | BNR | IMDX | CSTL | PSNL | XGN | |
|---|---|---|---|---|---|---|
| Market cap | 226.74M | 135.31M | 86.72M | 1.09B | 1.69B | 206.16M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -97.7 | -22.1 | -3.3 | -38.2 | -16.3 | -18.1 |
| Price/book | 24.8 | 1.9 | -4.1 | 2.3 | 6.2 | 16.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +144.77% | −10.33% | −58.86% | +4.68% | +105.61% | −19.26% |
| Today | +2.09% | +17.17% | −3.28% | +1.74% | +0.25% | +2.04% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All BDSX news ›CT-Based Pulmonary Segment Delineation: An Imaging Informatics Review of Methods, Benchmarks, Robustness, and Clinical Deployment
Unlock your free and exclusive access to all the news and expert commentary from the congress. Projected result for your current search:: 0 1.25 AMA PRA Category 1 Credits™ How can your team use biomarkers to improve diagnosis and…
All You Need to Know About Biodesix (BDSX) Rating Upgrade to Buy
Zacks Equity Research October 29, 2026 Biodesix, Inc. (BDSX Quick QuoteBDSX - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend…
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
Clinical Education and Implementation at CHEST 2026 Title : Precision Meets Protocol: Implementing Biomarkers into a Structured Nodule Management Care PathwayLocation : Learning Theater #4Date: Monday, October 19 | 10:15–11:00 am…
Analysts’ Top Healthcare Picks: 4D Molecular Therapeutics (FDMT), Biodesix (BDSX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on 4D Molecular Therapeutics (FDMT) and Biodesix (BDSX) with bullish sentiments. 4D Molecular Therapeutics (FDMT) In a report released today,…
Biodesix price target raised to $40 from $30 at TD Cowen
TD Cowen raised the firm’s price target on Biodesix (BDSX) to $40 from $30 and keeps a Buy rating on the shares. The firm adjusted targets in th... Biodesix price target raised to $40 from $30 at TD Cowen TD Cowen raised the firm’s price…
Biodesix, Inc. to Report Third Quarter 2026 Financial Results on November 5
Biodesix will release Q3 financial results on November 5, followed by a conference call at 4:30 PM ET. Biodesix will release its third-quarter financial results on November 5, 2026, after the market closes. The Biodesix conference call is…
Biodesix Advances Tumor-Informed and Tumor-Naïve MRD Assays
Oct 21, 2026 | Cancer, Molecular Diagnostics | Biodesix has announced strategic progress across two collaborative programs developing tumor-informed and tumor-naïve molecular residual disease (MRD) solutions for cancer centers and clinical…
Biodesix adds lung imaging test to pipeline with 2028 launch target
The Vanderbilt development partnership will pair CT imaging with blood biomarkers, with initial performance data due Dec. 3. A lung-nodule imaging test is headed for a Dec. 3 data presentation after Biodesix, Inc. NASDAQBDSX added digital…
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.…
Non-operating income (total) of Bioextrax AB TEMP – OMXSTO:BIOEX_BTU
Bioextrax AB engages in the development and commercialization of bio-extraction platform technology. It develops, tests, and verifies a potent microbial strain that can extract a variety of pure polyhydroxyalkanoates (PHA) bio-plastic…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- markets.businessinsider.com5
- mugglehead.com1
- quiverquant.com1
- tradingview.com1
- zacks.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.